卵巢癌手术后再次入院:我们是否在衡量手术质量?
本研究基于NSQIP数据库2012至2013年2806例卵巢癌手术患者,分析再次入院与术后主要并发症(Claviden-Dindo分级3级及以上)的关联。结果显示主要并发症与后续再次入院无关(RR 1.2,95%CI 0.7-1.9),41.4%的再次入院无任何主要并发症归因。作者认为质量指标基准和降低再次入院的努力应考虑这一高比例。
要点
- 卵巢癌手术后30天内9.1%(259/2806)发生非计划再次入院。
- 主要并发症与后续再次入院无关(RR 1.2,95%CI 0.7-1.9)。
- 41.4%的再次入院无任何主要术后并发症归因。
核心结论
- 卵巢癌手术后约40%的非计划再次入院发生于未发生主要术后并发症的患者。
- 质量指标基准和降低再次入院的努力应考虑这一高比例的无主要并发症归因的再次入院。
研究设计与样本
- 回顾性队列研究,数据来自美国国家手术质量改进项目(NSQIP)。
- 纳入2012年至2013年接受卵巢癌手术的患者2806例。
- 主要并发症定义为经效度验证的Claviden-Dindo量表3级或以上并发症,包括NSQIP定义和非NSQIP定义(基于再次入院ICD-9编码)的并发症。
- 采用率比和改良Poisson回归分析术后30天内的再次入院和并发症。
主要发现
- 2806例卵巢癌患者中9.1%(n=259)发生非计划再次入院。
- 总体主要并发症发生率为10.9%(n=307)。
- 住院期间主要并发症与后续再次入院无关(RR 1.2,95%CI 0.7-1.9)。
- 41.4%的再次入院无任何主要术后并发症归因。
- 非计划再次入院中55.2%(n=143)从未发生NSQIP定义的主要并发症;这143例中107例再次入院原因已知:28.0%为非NSQIP定义的主要并发症,16.8%为癌症或其他医疗因素,22.4%为轻微并发症,32.7%为有症状但未诊断并发症。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Readmission after surgery is a quality metric hypothesized to reflect the quality of care in the index hospitalization. We examined the link between readmissions and a surrogate of surgical quality - major postoperative complication - among ovarian cancer patients. METHODS: Patients who underwent surgery for ovarian cancer between 2012 and 2013 were identified from the National Surgical Quality Improvement Project (NSQIP). Major complications were defined as grade 3 or ≥complications on the validated Claviden-Dindo scale and included both NSQIP and non-NSQIP defined complications based on readmission ICD-9 code. Readmissions and complications within 30-days of surgery were analyzed using rate ratios and modified Poisson regression. RESULTS: We identified 2806 ovarian cancer patients of whom 9.1% (n=259) experienced an unplanned readmission. Overall major complication rate was 10.9% (n=307). Major complications in the index hospitalization were not associated with subsequent readmission (RR 1.2, 95% CI 0.7-1.9). Overall, 41.4% of readmissions were not attributable to any major postoperative complication. Of the unplanned readmissions, 55.2% (n=143) never experienced a NSQIP-defined major complication. Of these 143 patients, the reason for readmission was known for 107 patients and was: 28.0% non-NSQIP-defined major complications; 16.8% cancer or other medical factors; 22.4% minor complications; and 32.7% symptoms without a diagnosis of complication. CONCLUSIONS: Forty percent of unplanned readmissions after ovarian cancer surgery occur among patients who have not experienced a major postoperative complication. Quality metric benchmarks and efforts to decrease readmissions should account for this high percentage of readmissions not associated with a major complication.
引用
- Barber EL, Doll KM, Gehrig PA, et al. Hospital readmission after ovarian cancer surgery: Are we measuring surgical quality? Gynecol Oncol. 2017. PMID: 28522108. doi:10.1016/j.ygyno.2017.05.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。